Technology News and Research

RSS

Deep abdominal muscle activation lessens lower back pain

Improving transversus abdominis slide appears to be associated with clinically important long-term pain reduction in people experiencing lower back pain, researchers report.

21 Aug 2012

CHD patients do not need to rule out high-intensity exercise

Findings from a retrospective study show that patients with coronary heart disease who engage in high-intensity exercise have a similarly low risk for a cardiovascular event as those engaging in moderate-intensity exercise.

21 Aug 2012

Innovative Therapies forum focuses on topics across wound care settings, surgical disciplines

Modern Negative Pressure Wound Therapy (NPWT) has been in practice since the late 1970's when plastic surgeon Dr. Paul Svedman began treating patients. It is estimated that over half a million patients in the United States receive NPWT every year, but that millions more would benefit from the therapy if it were more accessible.

21 Aug 2012

New silicon chips help identify patients with lupus

Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon chips normally used in computer microprocessors.

21 Aug 2012

DPT Labs, Imprimis sign agreement to commence work on Impracor clinical supplies

Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials.

21 Aug 2012

New tool reveals surprising clues about how cancer cells respond to therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.

21 Aug 2012

HemoSep device significantly reduces need for blood transfusions during major surgeries

A pioneering surgical blood salvage technology developed at the University of Strathclyde, Glasgow, is set to transform the way major surgery is carried out by reducing blood loss in patients.

21 Aug 2012

Bonovo’s first PEEK lateral interbody fusion cage now available in China

Bonovo Orthopedics, Inc. announced today that it has launched the first PEEK lateral interbody fusion cage, Cross-Fuse in China.

21 Aug 2012

New model more effective in predicting individuals at high risk of lung cancer

A lung cancer risk prediction model developed by scientists at the University of Liverpool has been shown to be a viable tool for selecting high risk individuals for prevention and control programmes.

21 Aug 2012

Platelet-like nanoparticles nearly double survival rate after internal injury

Nanoparticles tailored to latch onto blood platelets rapidly create healthy clots and nearly double the survival rate in the vital first hour after injury, new research shows.

21 Aug 2012

Siemens, Arkansas complete $10M agreement for Soarian health IT solution

Siemens recently completed a 10-year, $10 million agreement, which included $4.8 million of financing, with Arkansas Heart Hospital for the acquisition and implementation of the Soarian® healthcare information technology (IT) solution.

From Siemens Healthineers 21 Aug 2012

Portable Micro-Plasma Device may help repair skin after laser surgery

A National Cheng Kung University (NCKU) research team has designed a Portable Micro-Plasma Device (PMPD) that may be the ultimate solution to repairing the skin after laser surgery.

21 Aug 2012

New neurotechnology aims to help rehabilitate stroke survivors

What comes naturally to most people - to think and then do - is difficult for stroke patients who have lost the full use of their limbs. New research by Rice University, the University of Houston (UH) and TIRR Memorial Hermann aims to help victims recover that ability to the fullest extent possible with a $1.17 million grant from the National Institutes of Health (NIH) and the President's National Robotics Initiative (NRI).

21 Aug 2012

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical trial to examine a two-month sustained release drug (OTX-TP2) for the treatment of ocular hypertension and glaucoma.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

Injectable controlled-release capsules against gum disease

Scientists are trying to open a new front in the battle against gum disease, the leading cause of tooth loss in adults and sometimes termed the most serious oral health problem of the 21st century. They described another treatment approach for the condition in a report here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

20 Aug 2012

IntegenX introduces rapid human DNA analysis system

IntegenX Inc., a leading developer of rapid human DNA identification technology, today launched its RapidHIT Human DNA Identification System to the European law enforcement and forensic communities at the 6th European Academy of Forensic Science (EAFS) Conference in The Hague, The Netherlands.

20 Aug 2012